Finding accredited CPD
The educational activity aims to reorient practitioners in the community setting to the evolving epidemiology of RSV in Australia. While RSV can lead to children becoming severely unwell and hospitalised, the majority of children will be assessed in the first instance by their GP.
As RSV lay relatively dormant during COVID, most clinician focus was on the identification of that illness during the COVID pandemic. Relaxed COVID restrictions has resulted in changing RSV patterns and severity of infection. It is important to re-focus attention to non-COVID respiratory infections in children, with particular emphasis on children at particular risk of poor outcomes. Use of evidence-based care in the community and signals for escalating care to tertiary settings is called for. Emerging treatments and preventive measures will play a role in mitigating the effect of this disease.
Sponsored: This activity is sponsored by Sanofi.
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.
Provided by
Educational Activities (EA) - 1.30
Reviewing Performance (RP) - 0.0
Measuring Outcomes (MO) - 0.0
You have to log in to see the content of this module.
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)